Co-Diagnostics, Inc.

CODX

Co-Diagnostics, Inc.

CODX

Insider Sentiment (TTM):

Last Purchase:2023-03-20Last Sale:2021-09-08Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:49,170Shares Outstanding:2,253,474Institutional Ownership Pct.:2.18%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	4	8	12	11	11	2	3	11	14	23	15	10
Marketable Securities Current	-	-	-	-	2	20	27	27	31	27	44	53
Accounts Receivable Net Current	0	0	0	0	0	0	0	0	1	0	0	1
Inventory Net	1	1	1	1	1	1	1	1	1	2	2	5
Income Tax Receivable	-	-	-	-	-	-	-	-	-	-	0	1
Income Taxes Receivable	0	0	0	1	-	-	-	-	-	-	-	-
Prepaid Expense And Other Assets Current	1	1	1	1	1	1	1	1	1	2	2	1
Notes And Loans Receivable Net Current	-	-	-	-	-	-	-	-	-	-	-	0
Assets Current	5	10	14	14	15	24	32	40	48	54	62	71
Property Plant And Equipment Net	2	2	2	2	3	3	3	3	3	3	3	3
Deferred Income Tax Assets Net	-	-	-	-	-	-	-	-	-	-	-	4
Operating Lease Right Of Use Asset	2	2	1	1	2	2	2	2	3	3	3	3
Intangible Assets Net Excluding Goodwill	7	7	7	26	26	26	26	26	26	26	26	26
Real Estate Investments Joint Ventures	-	-	-	-	-	-	-	-	-	1	1	1
Investments In Affiliates Subsidiaries Associates …	0	0	0	1	1	1	0	1	1	-	1	-
Assets	17	21	25	45	46	55	64	72	81	87	95	109
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	2	2	1	2	3	3	2	2	2	1	1
Accrued Liabilities Current	1	1	1	1	1	2	3	2	2	1	2	2
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	1	1	1
Asset Acquisition Contingent Consideration Liabili…	0	0	0	0	0	0	1	1	1	1	1	1
Contract With Customer Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	3	4	4	4	4	5	7	6	5	5	6	5
Liabilities Noncurrent
Operating Lease Liability Noncurrent	1	1	1	1	1	1	1	1	2	2	2	2
Asset Acquisition Contingent Consideration Liabili…	-	-	-	-	-	0	0	1	1	0	1	0
Liabilities Noncurrent	1	1	1	1	2	2	2	3	3	3	4	4
Liabilities	4	5	4	5	5	7	10	9	8	8	9	9
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Treasury Stock Value	-16	-16	-16	-16	-16	-16	-16	-16	-16	-16	-16	-15
Additional Paid In Capital	124	121	117	109	105	104	102	101	100	98	97	95
Accumulated Other Comprehensive Income Loss Net Of…	-	-	-	0	0	0	0	0	0	0	0	1
Retained Earnings Accumulated Deficit	-96	-90	-80	-54	-48	-41	-33	-22	-12	-5	5	19
Stockholders Equity	13	16	21	40	41	47	54	64	72	78	86	99
Liabilities And Stockholders Equity	17	21	25	45	46	55	64	72	81	87	95	109
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	5	4	30	2	1	1	1	1	1	1	1	1
Shares Outstanding	5	4	30	2	1	1	1	1	1	1	1	1
Treasury Stock Common Shares	0	0	0	0	5	5	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	245.40%	83.44%	-11.66%	-	-	-	-	-	-	-	-	-
2025	-27.89%	-25.92%	-21.13%	16.98%	44.91%	73.58%	0.81%	-50.18%	-78.69%	-10.22%	172.58%	81.18%
2024	-14.63%	1.63%	-8.94%	36.27%	20.59%	20.59%	-24.49%	-38.14%	-31.86%	-11.48%	-23.47%	-29.59%
2023	-	-	-	-	-	-	1.57%	4.72%	-0.79%	2.52%	1.68%	-11.76%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.81	2.28	3.87	3.81	4.12	4.43	4.41	6.92	9.09	10.19	10.81	13.99
Quick Ratio	1.29	1.94	3.42	3.36	3.66	4.02	4.08	6.53	8.56	9.56	10.24	12.85
Working Capital	2.33M	5.50M	10.15M	10.36M	11.60M	18.45M	24.98M	34.31M	42.91M	48.43M	56.39M	66.21M
Leverage & Debt
Debt to Equity	0.31	0.34	0.20	0.12	0.13	0.15	0.18	0.13	0.11	0.11	0.11	0.09
Debt Ratio	0.23	0.25	0.17	0.11	0.11	0.13	0.15	0.12	0.10	0.10	0.10	0.08
Efficiency & Turnover
Asset Turnover TTM	0.02	0.02	0.01	0.01	0.02	0.05	0.05	0.08	0.09	0.07	0.06	0.04
Days Sales Outstanding TTM	66.54	55.58	94.68	84.14	138.64	29.81	20.35	24.55	32.93	85.73	100.67	343.52
Receivables Turnover TTM	5.49	6.57	3.86	4.34	2.63	12.25	17.94	14.87	11.08	4.26	3.63	1.06
Per Share Metrics
Diluted EPS TTM	-10.92	-21.52	-35.25	-25.51	-32.61	-33.57	-37.22	-40.66	-37.45	-39.13	-36.16	-43.53
Free Cash Flow Per Share TTM	-6.37	-12.86	-22.43	-25.21	-30.11	-27.94	-29.57	-26.43	-25.36	-26.41	-23.99	-23.02
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	43.48%	45.06%	64.28%	34.03%	39.60%	77.52%	74.48%	49.30%	59.83%	41.34%	38.57%	62.80%
Operating Profit Margin TTM	-6,787.59%	-7,076.61%	-8,058.83%	-6,995.70%	-3,861.06%	-1,097.15%	-1,023.75%	-546.37%	-423.56%	-644.14%	-626.92%	-1,223.66%
Net Profit Margin TTM	-6,523.04%	-6,753.69%	-7,533.62%	-6,336.27%	-3,586.00%	-1,025.29%	-961.37%	-563.91%	-411.19%	-582.36%	-518.68%	-913.67%
Growth Metrics
Net Revenue Growth (1Y)	-28.12%	-79.47%	-84.10%	-93.06%	-89.02%	-47.62%	-42.53%	57.16%	25.24%	-44.91%	-80.09%	-91.25%
Net Income Growth (1Y)	30.74%	35.25%	24.59%	-22.05%	-4.20%	-7.79%	6.53%	-3.00%	-0.98%	22.65%	148.15%	-380.65%
EPS Growth (1Y)	-66.52%	-35.88%	-5.29%	-37.27%	-12.92%	-14.22%	2.95%	-6.61%	-4.38%	21.17%	166.19%	-399.38%
Valuation Metrics
P/E TTM	-0.28	-0.09	-0.14	-0.40	-0.26	-0.28	-0.60	-0.92	-1.00	-0.86	-1.10	-0.73
P/B TTM	1.05	0.26	0.33	0.33	0.23	0.21	0.42	0.60	0.52	0.43	0.45	0.31
P/S TTM	18.52	5.84	10.83	25.64	9.24	2.84	5.81	5.20	4.12	5.00	5.72	6.67
Market Cap	13.36M	4.19M	6.74M	13.02M	9.27M	9.94M	22.75M	38.08M	37.62M	33.39M	38.99M	31.09M
Enterprise Value	9.71M	-4.04M	-5.14M	1.58M	-1.84M	8.03M	19.81M	27.28M	23.76M	10.29M	24.08M	20.85M
Calculated Values
Free Cash Flow TTM	-27.47M	-28.99M	-29.84M	-31.81M	-33.23M	-29.85M	-29.90M	-26.84M	-25.44M	-26.24M	-23.45M	-22.51M
Net Debt	-3.65M	-8.23M	-11.88M	-11.44M	-11.12M	-1.90M	-2.94M	-10.80M	-13.86M	-23.10M	-14.92M	-10.24M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2023-03-20Purchase

Owner: Brown, Brian Lee

Title: Chief Financial Officer

Shares: 3,000

Price/Share: $1.90

Value: $5,700.00

Shares Owned: 76,236

Relationship: Officer

Ownership: Direct

2021-09-08Sale

Owner: Durenard, Eugene

Title: -

Shares: 2,000

Price/Share: $10.46

Value: $20,920.00

Shares Owned: -

Relationship: Director

Ownership: Direct

2021-05-19Sale

Owner: Benson, Reed L

Title: General Counsel

Shares: 108,334

Price/Share: $8.53

Value: $924,089.02

Shares Owned: -

Relationship: Officer

Ownership: Direct

2021-01-15Sale

Owner: Egan, Dwight H

Title: Chief Executive Officer

Shares: 38,046

Price/Share: $11.00

Value: $418,506.00

Shares Owned: -

Relationship: Director,Officer

Ownership: Direct

2021-01-14Sale

Owner: Serbin, Richard S

Title: -

Shares: 10,000

Price/Share: $10.29

Value: $102,900.00

Shares Owned: 2,500

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2023-03-20	Brown, Brian Lee	Officer	Chief Financial Officer	Direct	Purchase	3,000	1.90	$5,700.00	76,236	4
2021-09-08	Durenard, Eugene	Director	-	Direct	Sale	2,000	10.46	$20,920.00	0	4
2021-05-19	Benson, Reed L	Officer	General Counsel	Direct	Sale	108,334	8.53	$924,089.02	0	4
2021-01-15	Egan, Dwight H	Director,Officer	Chief Executive Officer	Direct	Sale	38,046	11.00	$418,506.00	0	4
2021-01-14	Serbin, Richard S	Director	-	Direct	Sale	10,000	10.29	$102,900.00	2,500	4
2021-01-13	Nelson, James B	Director	-	Direct	Sale	12,500	10.14	$126,750.00	0	4
2021-01-13	Durenard, Eugene	Director	-	Direct	Sale	10,500	10.09	$105,945.00	2,000	4
2020-12-14	Serbin, Richard S	Director	-	Direct	Sale	17,000	10.10	$171,700.00	0	4
2020-12-10	Durenard, Eugene	Director	-	Direct	Sale	10,000	10.15	$101,500.00	0	4
2020-11-25	Benson, Reed L	Officer	CFO and Secretary	Direct	Sale	89,524	10.50	$940,002.00	0	4
2020-11-24	Egan, Dwight H	Director,Officer	Chief Executive Officer	Direct	Sale	44,764	10.51	$470,469.64	0	4
2020-05-28	Serbin, Richard S	Director	-	Direct	Sale	25,000	18.02	$450,500.00	0	4
2020-05-26	Durenard, Eugene	Director	-	Direct	Sale	25,000	18.24	$456,000.00	0	4/A
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

2.18%

Inst. Shares: 49,170

Shares Outstanding: 2,253,474

2025-12-31

Inst. Shares: 5,542,504

Shares Outstanding: 1,330,200

2025-09-30

Inst. Shares: 5,324,525

Shares Outstanding: 1,261,768

2025-06-30

Inst. Shares: 5,117,418

Shares Outstanding: 1,102,510

2025-03-31

Inst. Shares: 5,774,362

Shares Outstanding: 1,068,299

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	49,170	2,253,474	2.18%
2025-12-31	5,542,504	1,330,200	-
2025-09-30	5,324,525	1,261,768	-
2025-06-30	5,117,418	1,102,510	-
2025-03-31	5,774,362	1,068,299	-
2024-12-31	5,636,651	1,011,179	-
2024-09-30	4,391,926	1,015,457	-
2024-06-30	4,549,962	1,003,152	-
2024-03-31	3,749,093	993,768	-
2023-12-31	4,045,315	977,242	-
2023-09-30	3,922,866	977,731	-
2023-06-30	3,772,725	968,636	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Co-Diagnostics, Inc. (CODX) — SEC Financial Statements & Analysis

Co-Diagnostics, Inc. (CODX) is a surgical & medical instruments & apparatus company, incorporated in UT. Co-Diagnostics, Inc. trades on Nasdaq as: CODX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Co-Diagnostics, Inc. reported a -28.12% year-over-year revenue growth, a Gross Profit Margin of 43.48% (TTM), a Debt-to-Equity ratio of 0.31x, a Price-to-Sales (P/S) ratio of 18.52x (TTM), a Price-to-Book (P/B) ratio of 1.05x (TTM), at a market cap of $13.36M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -28.12%
Gross Profit Margin TTM: 43.48%
Debt To Equity: 0.31x
P/S TTM: 18.52x
P/B TTM: 1.05x
Market Cap: $13.36M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Co-Diagnostics, Inc. in?

Co-Diagnostics, Inc. (CODX) operates in the Surgical & Medical Instruments & Apparatus industry.

What is CODX's market cap?

Co-Diagnostics, Inc. (CODX) has a market capitalization of $13.36M as of 2026-06-30.

What exchange does CODX trade on?

Co-Diagnostics, Inc. (CODX) trades on the Nasdaq.

Where is Co-Diagnostics, Inc. incorporated?

Co-Diagnostics, Inc. is incorporated in UT.